首页> 外文期刊>American journal of medical genetics, Part B. Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics >Influence of family history of dementia in the development and progression of late-onset Alzheimer's disease
【24h】

Influence of family history of dementia in the development and progression of late-onset Alzheimer's disease

机译:痴呆症家族史对迟发性阿尔茨海默氏病发展和进程的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Family history of dementia (FH) is a recognized risk factor for developing late-onset Alzheimer's disease (AD). We asked whether having FH increases AD risk and influences disease severity (age at onset and cognitive impairment) in 420 AD patients and 109 controls with (FH+) or without (FH-). The relationships of APOE and other AD risk genes with FH were analyzed as well. The proportion of APOE e4 allele carriers was higher among the FH+ than the FH- AD patients (49.6% vs. 38.9%; P=0.04). The distribution of the risk genotypes of nine AD susceptibility genes previously examined (CHAT, CYP17, CYP19, ESR1, FSHR, P53, P73, P21, PPARG) did not differ between the FH+ and the FH- AD patients, indicating that none contributed significantly to familial clustering of disease. FH was associated with an increased AD risk (odds ratio [OR] 2.71, 95% confidence interval [CI] 1.44-5.09; P=0.002) independent of carrying the APOE e4 allele (OR 2.61, 95%CI 1.53-4.44; P=0.0004). Having a first-degree relative or a parent with dementia was significantly associated with AD risk (OR 2.9, 95%CI 1.3-6.4; P=0.009 and OR 2.7, 95%CI 1.1-6.2; P=0.02) but having a sibling with dementia was not (OR 1.7, 95%CI 0.2 to 14.7; P=0.6). Among the FH+ AD patients, having one or both parents affected seemed to raise the risk of earlier onset age (P=0.02) and greater cognitive impairment (P=0.02) than having only an affected sibling, whereas having two or more affected relatives did not. (c) 2015 Wiley Periodicals, Inc.
机译:痴呆症家族史(FH)是公认的发展迟发性阿尔茨海默氏病(AD)的危险因素。我们询问在有(FH +)或没有(FH-)的420名AD患者和109名对照中,是否患有FH会增加AD风险并影响疾病严重程度(发病年龄和认知障碍)。还分析了APOE和其他AD风险基因与FH的关系。 FH +患者中APOE e4等位基因携带者的比例高于FH-AD患者(49.6%比38.9%; P = 0.04)。 FH +和FH-AD患者之间先前检查过的9种AD易感基因(CHAT,CYP17,CYP19,ESR1,FSHR,P53,P73,P21,PPARG)的风险基因型分布没有差异,表明没有明显的贡献家族性疾病的聚集。 FH与携带APOE e4等位基因(OR 2.61,95%CI 1.53-4.44; P无关)的AD风险增加有关(风险比[OR] 2.71,95%置信区间[CI] 1.44-5.09; P = 0.002)。 = 0.0004)。具有一级亲戚或父母患有痴呆症与AD风险显着相关(OR 2.9,95%CI 1.3-6.4; P = 0.009和OR 2.7,95%CI 1.1-6.2; P = 0.02),但具有同胞痴呆的患者没有(OR 1.7,95%CI 0.2至14.7; P = 0.6)。在FH + AD患者中,与只有一个患病兄弟姐妹相比,有一个或两个父母患病的患病年龄似乎增加了更早发病(P = 0.02)和更大的认知障碍(P = 0.02)的风险,而有两个或更多患病亲属的患病风险却更高。不。 (c)2015年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号